Clinical Trials Logo

Clinical Trial Summary

Prospective drug interaction study during pregnancy.


Clinical Trial Description

A randomized pharmacokinetic study to evaluate CYP2D6 activity with and without vitamin A administration during pregnancy and compared to postpartum control. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03117660
Study type Interventional
Source University of Washington
Contact
Status Completed
Phase Phase 1
Start date July 25, 2017
Completion date October 31, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04228315 - Biomarkers of P. Vivax Relapse N/A
Completed NCT01075802 - Study of Tamoxifen Dose Escalation in Breast Cancer Patients With CYP2D6 Polymorphisms N/A
Completed NCT03076021 - Effects of Isotretinoin on CYP2D6 Activity Phase 4
Completed NCT03411759 - Cytochrome P450's Pharmacogenomics in Chronic Pain Patients
Completed NCT02428660 - Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM N/A
Enrolling by invitation NCT03137368 - A Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations (STEP) Phase 3
Completed NCT02664350 - Precision Medicine Guided Treatment for Cancer Pain N/A